Owlet Inc. is a pioneering leader in infant health technology, dedicated to improving the safety and well-being of newborns through innovative monitoring solutions. Its flagship product, the Owlet Smart Sock, utilizes advanced pulse oximetry to provide continuous tracking of infants' heart rates and oxygen levels, offering critical health insights directly to parents' mobile devices. As the demand for pediatric health monitoring continues to rise, Owlet is well-equipped to expand its product offerings and enhance its market position in the rapidly evolving infant health sector. By prioritizing actionable data for parents and advancing pediatric care, Owlet is establishing a significant presence at the convergence of healthcare and technology.
| Revenue (TTM) | $105.71M |
| Gross Profit (TTM) | $53.53M |
| EBITDA | $-8.06M |
| Operating Margin | -18.40% |
| Return on Equity | -802.00% |
| Return on Assets | -7.64% |
| Revenue/Share (TTM) | $5.84 |
| Book Value | $0.71 |
| Price-to-Book | 6.12 |
| Price-to-Sales (TTM) | 1.32 |
| EV/Revenue | 1.26 |
| EV/EBITDA | -0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 29.60% |
| Shares Outstanding | $28.16M |
| Float | $15.81M |
| % Insiders | 5.02% |
| % Institutions | 71.53% |